Company / SG&A per Share
Axogen, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.01
FY2025
5-year range
$0.63 / $1.01
FY2021-FY2025
Trend
+11.5%
vs FY2024
Sector context
#135 of 156
Health Care
What the data says
Axogen, Inc.'s sg&a per share of $1.01 is lower than 87% of companies in the Health Care sector (FY2025). SG&A per Share has increased for 3 consecutive years, from $0.63 in FY2022 to $1.01 in FY2025.
Based on SEC 10-K filings.
1.01 in FY2025 with a 5-year CAGR of +11.6%.
Increased from $0.90 to $1.01 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +16.9%
- 5-Year CAGR
- +11.6%
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 156This company $1.01 Sector average $11421.53
▼
-100.0% below sector average
Key checks
Key Insights
- Axogen, Inc.'s sg&a per share has grown for 3 consecutive years.
- In FY2025, sg&a per share increased 11.5% year-over-year.
- Ranks #135 out of 156 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- Negative profit margin: -5.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.01 | +11.5% |
| FY2024 | $0.91 | +0.0% |
| FY2023 | $0.90 | +43.1% |
| FY2022 | $0.63 | -17.9% |
| FY2021 | $0.77 | +31.9% |
| FY2020 | $0.58 | -27.4% |
| FY2019 | $0.80 | +172.8% |
| FY2018 | $0.29 | -33.9% |
| FY2017 | $0.45 | +58.9% |
| FY2016 | $0.28 | -35.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026